<DOC>
	<DOCNO>NCT01192659</DOCNO>
	<brief_summary>The purpose study identify risk factor low lymphocyte count among patient type 2 diabetes treat oral antidiabetic drug .</brief_summary>
	<brief_title>Risk Factors Low Lymphocyte Count Patients With Type 2 Diabetes</brief_title>
	<detailed_description>Involving secondary analysis data collect prospectively define cohort , SAVOR trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Lymphopenia</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>Enrolled SAVOR Diagnosed T2DM Baseline HbA1c â‰¥6.5 % ( base last measured document laboratory measurement within 6 month ) Age 40 old High risk cardiovascular event Not enrol SAVOR Current previous treatment DPP4 inhibitor and/or GLP1 incretin mimetics . Acute vascular event Pregnancy HIV/AIDS Severe autoimmune disease Current chronic steroid use</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>